Azitra is trading 7.17% up now at $0.17 after investors continued reacting on August 26, 2026, to its August 21 announcement that NYSE American confirmed restoration of compliance with all continued-listing standards.
- The exchange will remove Azitra’s below-compliance indicator and noncompliant-issuer listing, improving its listing outlook.
- No newer company-specific announcement was identified during the session; broader biotech strength provided additional support.